NCT07009028 The Effect of Storigami Method on Pain, Fear and Anxiety Levels Associated With Peripheral Intravenous Catheterisation in Children
| NCT ID | NCT07009028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ege University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2025-08-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-05-20 with a primary completion date of 2025-08-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study was to determine the effect of storigami method on reducing pain, fear and anxiety of children in peripheral intravenous catheter applications in children aged 6-9 years who were hospitalized in the pediatric health and diseases clinic.
Eligibility Criteria
Inclusion Criteria: * Volunteering to participate in the study * The child is between 6-9 years old * First time peripheral intravenous catheter insertion since admission to the clinic * The child has no vision, hearing and speech problems * The child has no mental retardation * Know/speak Turkish * No complaints such as pain, nausea and vomiting that may affect fear and anxiety * No sedative or analgesic was given to the child immediately before the peripheral intravenous catheterization procedure Exclusion Criteria: * The child has a chronic, congenital, metabolic or neurodegenerative disease * Failed attempt at peripheral intravenous catheterization, * Failure to complete or incomplete completion of questionnaires, * A different invasive intervention was performed immediately before PIC application, * The child does not comply during the procedure, * The child wants to leave the study
Contact & Investigator
Ayşe Kahraman, Assoc Prof
PRINCIPAL INVESTIGATOR
Ege Universty
Frequently Asked Questions
Who can join the NCT07009028 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 9 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07009028 currently recruiting?
Yes, NCT07009028 is actively recruiting participants. Contact the research team at eminacubukcu@gmail.com for enrollment information.
Where is the NCT07009028 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye), Izmir, Turkey (Türkiye).
Who is sponsoring the NCT07009028 clinical trial?
NCT07009028 is sponsored by Ege University. The principal investigator is Ayşe Kahraman, Assoc Prof at Ege Universty. The trial plans to enroll 120 participants.